This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

B. J. Stern, MD; S. A. Schonfeld, MD; C. Sewell, RN, MS, CRNP; A. Krumholz, MD; P. Scott, MD; G. Belendiuk, MD, PhD

Arch Neurol. 1992;49(10):1065-1072.

Abstract
• Six patients with refractory neurosarcoidosis were enrolled in a 12-month open-label trial to investigate the safety and efficacy of cyclosporine therapy. Patients were stabilized on a corticosteroid dose, randomized to a low-dose or high-dose cyclosporine group (with appropriate target whole blood cyclosporine levels) for 6 months, and assessed by prospectively defined studies. The corticosteroid dose was adjusted as clinically tolerated. We found that the corticosteroid dose could be lowered to 30% to 58% of the initial stabilization dose in conjunction with cyclosporine therapy, at the time of maximal clinical and laboratory improvement. However, four patients deteriorated while using corticosteroids and cyclosporine; one of these patients died. At the time of clinical deterioration, the prednisone dose ranged from 6 to 22.5 mg daily (or the equivalent). No serious toxic effects developed from cyclosporine therapy. Cyclosporine treatment is a reasonably safe and effective adjunct to corticosteroid therapy for patients with refractory neurosarcoidosis, although clinical deterioration can occur despite combination therapy.

Author Affiliations
From the Department of Medicine, Divisions of Neurology (Drs Stern and Krumholz and Ms Sewell) and Pulmonary Medicine (Drs Schonfeld and Scott), Sinai Hospital of Baltimore (Md); the Departments of Neurology (Drs Stern and Krumholz), and Medicine (Dr Schonfeld and Scott), The Johns Hopkins Medical Institutions, Baltimore, Md; and the Sandoz Research Institute, East Hanover, NJ (Dr Belendiuk). Dr Krumholz is currently with the Department of Neurology, University of Maryland at Baltimore; Dr Scott, with the Church Hospital Corporation, Baltimore, Md; and Dr Belendiuk, with Pharmavene Inc, Gaithersburg, Md.

Footnotes
Accepted for publication May 21, 1992.

Presented, in part, at the 41st Annual Meeting of the American Academy of Neurology, Chicago, III, April 17, 1989.

Reprint requests to Division of Neurology, Sinai Hospital of Baltimore, 2401 W Belvedere Ave, Baltimore, MD 21215 (Dr Stern).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
Lynch
ACCP Pulmonary Med Brd Rev 2009;25:635-686.
FULL TEXT  

Interstitial lung disease guideline
Wells et al.
Thorax 2008;63:v1-v58.
FULL TEXT  

Sarcoidosis of the nervous system
Joseph and Scolding
PN 2007;7:234-244.
ABSTRACT | FULL TEXT  

Treatment of Corticosteroid-Resistant Neurosarcoidosis With a Short-Course Cyclophosphamide Regimen
Doty et al.
Chest 2003;124:2023-2026.
ABSTRACT | FULL TEXT  

Endocrine and reproductive manifestations of sarcoidosis
Porter et al.
QJM 2003;96:553-561.
FULL TEXT  

Statement on Sarcoidosis
Hunninghake
Am. J. Respir. Crit. Care Med. 1999;160:736-755.
FULL TEXT  

Central nervous system sarcoidosis—diagnosis and management
Zajicek et al.
QJM 1999;92:103-117.
ABSTRACT | FULL TEXT  

Effectiveness of Chloroquine and Hydroxychloroquine in Treating Selected Patients With Sarcoidosis With Neurological Involvement
Sharma
Arch Neurol 1998;55:1248-1254.
ABSTRACT | FULL TEXT  

Neurosarcoidosis as a Cause of Refractory Psychosis: A Complicated Case Report
Bona et al.
Am. J. Psychiatry 1998;155:1106-1108.
FULL TEXT  

Diagnosis and Management of Neurological Sarcoidosis
Lower et al.
Arch Intern Med 1997;157:1864-1868.
ABSTRACT  

Sarcoidosis
Newman et al.
NEJM 1997;336:1224-1234.
FULL TEXT  

RESIDENT'S PAGE: IMAGING
BRYAN and ZINREICH
Arch Otolaryngol Head Neck Surg 1997;123:110-113.
ABSTRACT  

Case 37-1996- A 51-Year-Old Man with Visual Problems and an Intracranial Mass
Gittinger and Hedley-Whyte
NEJM 1996;335:1668-1674.
FULL TEXT  

Therapeutic Considerations in Patients With Refractory Neurosarcoidosis
Agbogu et al.
Arch Neurol 1995;52:875-879.
ABSTRACT  

Sarcoidosis Involving the Optic Nerve and Hypothalamus
Westlake et al.
Arch Ophthalmol 1995;113:669-670.